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1. Introduction 
The technique of measuring intracellular protein levels using flow cytometry is a very rapid 
method to detect protein on a single-cell level. 
The demand for determining protein levels in a continuously decreasing amount of input 
cells is currently being developed by scientists and medical doctors. Another demanding 
area is the splitting of active and inactive (phosphorylated and unphosphorylated, 
respectively) forms of the protein being monitored, e.g., during different phases of the cell 
cycle, differentiation or carcinogenesis. The Western blot technique has been typically 
used for this purpose. The utilization of multi color flow cytometry allows for 
measurements of multiple proteins in parallel, regardless of the protein length. As the 
technique evolves, it is possible to obtain information on over 13 parameters per cell 
(Krutzik et al., 2004). 
Measuring the phosphorylation status of specific proteins using this technique is very 
efficient. It eliminates a number of problems related either to Western blotting or ELISA. 
Compared to the Western blot, this progressive method has much lower requirements on 
the number of input cells (only 1 x 104 cells are needed for determining the concentration of 
a given protein), it requires less time for processing and, last but not least, is also much more 
cost effective. Furthermore, it allows researchers to distinguish the various cell populations 
in the sample without complicated cell separation, if the appropriate antibodies are used. 
This is beneficial for searching for cell populations and their reactions on external stimuli, 
such as changed cultivation conditions during in vitro experiments or influencing the 
organism during in vivo experiments.  
In this chapter, the application and pitfalls of flow cytometric intracellular protein 
measurements are illustrated by the data of our original research of porcine monocytes and 
CD34+ hematopoietic stem/progenitor cells. In short, a successful utilization of this 
progressive technique depends on correctly performing the 4 following steps:  
1. Precise experimental planning to obtain a defined cell population using this technique. 
2. Effective fixation and permeabilization of the cell population. 
3. Choosing the optimal isotype control. 
4. Selecting the optimal system of primary and secondary antibodies. 
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2. Fixation and permeabilization 
Intracellular flow cytometry, in comparison with conventional cell surface labeling methods, 
requires fixation and permeabilization of the cells before staining of intracellular antigens 
(Robinson et al., 1993). Moreover, a variety of commercial kits for fixation and 
permeabilization are available. 
The first step in the population analysis is high quality fixation. A crosslinking reagent 
(typically formaldehyde) could be used for this purpose. For every given cell population, it 
is necessary to test the adequate concentration of the solution. The most common 
formaldehyde concentration is about 4%. Other fixation limiting factors are time and 
temperature. The incubation time, according to the cell population type, varies between 8 
and 15 minutes. The incubation temperature is 37 °C. A variety of commercial kits for 
fixation and permeabilization are available. 
The following step is for permeabilization with detergents (Triton X 100 or saponin) or 
alcohol (ethanol or methanol). Although the protocols that have been used to stain 
phosphoepitopes for flow cytometry differ from one to another, they rely on two primary 
permeabilization reagents – saponin or methanol. 
Saponin permeabilization 
Saponin is a mixture of terpenoid molecules and glycosides that permeabilize cells by 
interacting with cholesterol present in the cell membrane (Melan et al. 1999). This creates 
pores in the plasma membrane that are large enough for entry of fluorophore-conjugated 
antibodies. Because the intracellular proteins can leak out of saponin-treated cells, they must 
be first exposed to a crosslinking reagent, such as formaldehyde, to cross-link proteins and 
nucleic acids into a cohesive unit within the cell. Saponin has become the detergent of choice 
for cytokine staining, and several groups have utilized it for permeabilization in phospho-
epitope staining protocols (Pala et al., 2000). It is typically used at concentrations ranging 
from 0.1% to 0.5%, similar to cytokine-staining procedures. 
Three commercially available kits (Leukoperm, Serotec, UK; Fix & Perm, An Der Grub, 
Austria; IntraStain, DAKO Cytomation, Denmark) along with combinations of 2 or 4% 
paraformaldehyde with 0.1 or 0.05% saponin were tested for fixation and permeabilization 
of isolated pig’s peripheral blood mononuclear cells or whole blood leukocytes (Zelnickova 
et al., 2007).  
The fixation and permeabilization process could lead to non-specific binding of primary or 
secondary antibodies. In comparison to all three tested commercial kits, a combination of 
paraformaldehyde and saponin caused an increase in non-specific binding of antibodies. 
The intensity of fluorescence of the negative peak of paraformaldehyde/saponin fixed cells 
was evidently higher in comparison with the negative peak of cells fixed with the use of 
commercial kits.  
The fixation and permeabilization process could lead to elevation of autofluorescence of 
cells. The autofluorescence of cells was at the lowest level in all tested kits. In contrast, the 
combination of paraformaldehyde and saponin in all concentrations caused an increase of 
autofluorescence. The autofluorescence in samples fixed with 4% paraformaldehyde was 
higher than with 2% paraformaldehyde. 
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The fixation and permeabilization process could damage the light scatter properties of the 
cells. The light scatter characteristics of all tested cells were comparable after any type of 
fixation and permeabilization. The light scatter characteristics were always changed in 
comparison with fresh preparations. However, well distinguishable and bounded 
subpopulations of mononuclear cells and neutrophils were obtained by adjusting the 
settings in the side and forward scatters. 
Some protocols use labeling of intracellular molecules in the whole blood instead of isolated 
blood leukocytes. In our laboratory, the lysis of red blood cells (RBC) is always performed 
before starting the staining procedure. However, in order to make the processing of large 
amounts of samples as quick as possible, the hemolysis is commonly performed in the 96-
well plate in which the cultivation was previously performed. The volume of the hemolytic 
reagent is therefore relatively small and the hemolysis is not complete. Therefore, it is 
advantageous if the fixation and permeabilization procedure leads to the lysis of these 
contaminating erythrocytes. It was found that only the IntraStain kit and 
paraformaldehyde/saponin fixation and permeabilization completely lysed RBC in the 
samples. The other two kits did not induce a lysis of porcine RBC (although complete lysis 
of human RBC was obtained by these kits in preliminary experiments, which is in 
accordance with the manufacturer’s instructions).  
The problem can occur when the lysis of RBC is performed before fixation and 
permeabilization. The lysis of RBC induced by ammonium chloride solution (the lysing 
reagent commonly used in our laboratory to lyse porcine RBC) before fixation and 
permeabilization with commercial kits strongly changed the light scatter characteristics of 
white blood cells (WBC). This was apparent, especially in neutrophils, which completely 
fused with the lymphocyte population. Moreover, the population of lymphocytes was much 
more dispersed as shown by the side scatter measurements. If the lysis of RBC was 
performed before their fixation and permeabilization with the IntraStain kit, and the cells 
were washed twice in CWS solution immediately after lysis, the scatters were not altered. If 
these washing steps were tested with the other two kits, the light scatters were changed. 
Thus, the lysis of RBC cannot be achieved with the Fix&Perm or Leukoperm kits without 
alteration of light scatter characteristics of WBC. 
Finally, the effect of different fixation/permeabilization reagents on IFN-γ and TNF-α 
staining was tested. Generally, we can say that commercial kits mostly gave better results 
compared with paraformaldehyde/saponin. IntraStain and Leukoperm gave better results 
than Fix&Perm in some cases. If the use of a combination of paraformaldehyde/saponin is 
considered, 0.05% saponin should be avoided, especially in combination with 2% 
paraformaldehyde. Saponin in a concentration of 0.1% in combination with 4% 
paraformaldehyde slightly increased the percentages of positive cells in comparison with 
2% paraformaldehyde. However, these differences were nonsignificant. 
Consistent with the above mentioned parameters, the IntraStain kit gave the best results 
compared to the other two tested kits, as well as when compared to 
paraformaldehyde/saponin. Therefore, this kit was chosen for fixation and permeabilization 
of porcine leukocytes for experimentation. 
Since a wide range of different fixation and permeabilization reagents that were not tested 
in our study are currently available, the above mentioned parameters can serve as a particular 
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protocol of intracellular cytokine detection and also as a suggestion for optimization of the 
fixation, permeabilization and cell surface labeling procedures for any laboratory. 
2.1 Methanol permeabilization 
Alcohol permeabilization has typically been used for the analysis of DNA by flow cytometry 
(Ormerod et al., 2002), but can be successfully applied to phospho-epitope staining as well 
(Krutzik et al., 2003). It is thought that alcohols fix and permeabilize cells by dehydrating 
them and solubilizing molecules out of the plasma membrane. Proteins may be made more 
accessible to antibodies during the process and cells are permeabilized to a greater extent 
than with saponin, allowing efficient access to the nuclear antigens. 
Another option is to use commercially available kits. Currently, there are a large number of 
them available on the market. A fact that needs to be taken into account when using the 
commercial kits is that even if the kit works well, the method cannot be excessively 
modified. This could be reflected in the scale of results. 
By using one of the best available kits for permeabilization, BD Fix&Perm, with methanol 
permeabilization during “The decrease in p-CrkL levels upon imatinib treatment” 
experiment, we came to the following conclusion: 
The method (permeabilization using BD Fix&Perm) is less sensitive. It does not recognize 
the difference between 0 µM and 5 µM imatinib (IM). The speed (2 hours) is an advantage 
and there is a smaller amount of necessary input material (cells) as well. Although the peaks 
are sharp, it seems to be more difficult for the antigens to get into the cell, because of less 
aggressive permeabilization. The methanol permeabilization is much more sensitive. It is 
able to recognize differences between 0 µM and 5 µM IM. It is more time consuming  
(5 hours) and requires a higher amount of input material (cells). The significant advantage is 
the customizability of the method according to user needs (Figure 1). 
3. Isotype control 
The selection of the appropriate isotype control is an important element in flow cytometry 
experiments. Isotype controls are antibodies of the same isotype as the target primary 
antibody. They are of unknown specificity or are raised against antigens known to be absent 
in target cells. Isotype controls are used to estimate non-specific staining of primary 
antibodies. Several factors can contribute to the levels of this “background” staining, 
including Fc receptor binding, non-specific protein interactions, and cell autofluorescence. 
These factors may vary depending on the target cell type and the isotype of the primary 
antibody. Therefore, isotype controls need to be properly chosen. Isotype control antibodies 
ideally match the primary antibody’s host species, isotype, and conjugation format. For 
example, if the primary antibody is an APC-conjugated mouse IgG2a, then it will be 
necessary to choose an APC-conjugated mouse IgG2a isotype control. Thus, isotype control 
is supposed to have all the non-specific characteristics of the target primary antibody and it 
is able to accurately determine the level of specific staining. Various monoclonal antibody 
idiotypes are used in flow cytometry applications: most frequently, IgG1, IgG2a, IgG2b, 
IgG3, IgM, and IgA; less frequently IgD, IgE, IgG2c, Ig kappa, and Ig lambda are applied. 
Designing the experiment, this isotype and origin species of the primary antibody must be 
known to find a suitable isotype control. The appropriate isotype control is subsequently 
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looked up in a company product list according to the desired isotype (IgG1, IgG2a, IgM, 
etc.), reactivity (mouse, human, rat, etc.), and conjugate (FITC, PE, APC, etc.). In addition, 
recommended isotype controls can often be found on the Data Sheets for primary  
 
Fig. 1. The difference between permeabilization protocols using (A) methanol and (B) the BD 
Fix&Perm kit. Permebilization with methanol is more sensitive and allows researchers to 
distinguish between individual MFI peaks. Fix&Perm kit is less time consuming with 
relatively low sensitivity 
www.intechopen.com
 
Flow Cytometry – Recent Perspectives 
 
426 
antibodies. Isotype control antibodies are commercially available for both direct and indirect 
immunofluorescence in the form of fluorochrome-conjugated antibodies and unconjugated 
antibodies, respectively. During the flow cytometry analysis, the idiotype control antibody 
is diluted to the same concentration as the specific primary antibody, and is used to stain the 
sample of negative control cells. This negative control serves to determine the amount of 
non-specific “background” fluorescence. It allows for setting a threshold of negativity of 
stained cells. Any event generating a signal above this baseline is considered to be 
specifically labeled with the target primary antibody.  
The isotype control plays an important role during the processing of final measurements. 
The level of monitored protein is determined as the geometric mean of fluorescent intensity 
(MFI) of labeled sample, minus the isotype control (O’Gorman et al., 1999, Holden et al., 
2006,Hulspas et al., 2009). 
 
Fig. 2. Representative FACS plot showing isotype and CrkL MFI peaks visualized by a FITC-
conjugated secondary antibody in CD34+ cells isolated from peripheral blood of a newly 
diagnosed CML patient. The MFI peak of isotype indicates the FITC unspecific background 
fluorescence. These were visualized using FlowJo software 
4. Intracellular antigens for flow cytometry 
The most common way to visualize of the complex between a monoclonal antibody and an 
antigen in flow cytometry is to covalently bind the antibody to different fluorescent 
molecules (fluorophores). After exposure to radiation from an excitation source, these 
fluorophores emit photons with longer wavelengths. Currently, there is a wide range of 
commercially available fluorophores starting from the small polycyclic molecules, such as 
fluorescein isothiocyanate (FITC), cyanines, and dyes of the Alexa series, through 
fluorescent phycobilipoproteins whose best-known representatives are phycoerythrin  
(PE), allophycocyanin (APC). New way in flow cytometry is also Qdot® nanocrystals –  
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nanometer-scale semiconductor particles with unique fluorescence properties (eBioscience , 
Molecular Probes®).. 
The world leader in bringing innovative diagnostic and research tools to different specialists 
are Beckman Coulter and eBioscience as the major companies producing unconjugated and 
conjugated antibodies for flow cytometry. BD Biosciences offers a number of Alexa Flouro 
(AF®) 488/647/700-, APC-, FITC-, PE-, and Pacific BlueTM- conjugated antibodies of BD 
PharmingenTM and BD PhosflowTM brands used for multicolor flow cytometry (BD 
Biosciences, 2011). 
A particularly strong area of leukemia immunophenotyping that contains a broad panel of 
research products has been built up by (DAKO, 2010). DAKO offers various types of 
reagents for use in flow cytometry, including primary single-color antibodies conjugated 
with a single fluorochrome; MultiMix™ Dual-Color Reagents based on the combination of 
two or more antibodies labeled with FITC and RPE; and MultiMix™ Triple-Color Reagents 
based on the combination of three antibodies labeled with fluorescein isothiocyanate (FITC), 
R-phycoerythrin (RPE) and allophycocyanin (APC) or FITC, RPE and RPE-Cy5. Other 
products for use in flow cytometry are isotype reagents, secondary antibody conjugates, 
streptavidine conjugates and other accessories. There are also several kits available, e.g. an 
apoptosis kit used for flow cytometric distinction between viable cells in single cell 
suspensions or an Enumeration of Stem Cells Kit used for optimal enumeration of CD34+ 
hematopoietic stem /progenitor cells (DAKO, 2010). 
Another strong company in the production of high-quality activation-state antibodies is Cell 
Signaling Technology. They offer a number of primary and conjugated antibodies as well as 
antibody-related kits. Conjugated antibodies are conjugated with AF®, PE or biotin (Cell 
Signaling Technology, 2011) 
There are many other companies not mentioned in the table, including R&D Systems, 
Miltenyi Biotec and BioLegend, that offer a wide range of unconjugated and conjugated 
monoclonal antibodies and kits. For example, R&D Systems offers a wide range of biotin-, 
fluorescein-, PE-, PerCP-, AF® 488-, or APC- conjugated monoclonal antibodies specifically 
designed to monitor protein expression by flow cytometry (R&D Systems, 2011). 
Generally, the problem with labeling various molecules for flow cytometry in animal species 
other than mice is the poor availability of directly conjugated primary antibodies. Therefore, 
indirect labeling is commonly used. This includes labeling cells with a non-conjugated 
antibody and subsequent visualization with a secondary fluorochrome-conjugated antibody. 
This indirect labeling is limited by the subclasses of primary antibodies, which should not 
share the same subclass. This limits the use of the antibodies, especially in the case of 
multicolor labeling.  
When intracellular labeling is combined with cell surface marker labeling in pigs, the 
problem with sharing the same subclasses is more noticeable since all the anti-porcine 
cytokine antibodies used share the most common mouse IgG1 subclass. The cell surface 
molecules are always labeled prior to the labeling of the intracellular cytokine in our 
protocol. Accordingly, the anti-cytokine antibody must be directly conjugated with 
fluorochrome (such as anti-TNF-α or anti-IFN-γ) or it must be biotinylated (such as anti-IL-2 
or anti-IL-10) or pre-labeled in some other way (Zelnickova et al., 2008). 
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Intracellular 
marker 
Type Clone 
name 
Isotype Reactivity Labelling Source Ref. 
Cytokines        
IL-2, IL-4, 
TNF- α, etc. 
mAb 5344.111, 
3010.211, 
6401.1111,
… 
Ms IgG1,κ Hu FITC/ 
PE/APC/… 
BD Biosciences Karanikas  
et al., 2000 
IFN- γ mAb P2G10 Ms IgG1,κ Pig PE-conjugate BD Biosciences Gerner  
et al., 2008 
Cell cycle or 
Apoptosis 
       
p53 mAb DO7 Ms IgG2b Hu nonconjugated Dako Millard  
et al., 1998 
bcl-2 mAb 124  Ms IgG1 Hu FITC-
conjugated 
Dako Millard  
et al., 1998 
rb mAb G3-245 Ms IgG1 Ms, Qua, Mn, Mk, 
Rat, Hu 
nonconjugated BD Biosciences Millard  
et al., 1998 
MDR1 mAb JSB-1 Ms IgG1 Hu, Rat, Ms nonconjugated Millipore Millard  
et al., 1998 
PCNA mAb PC10 Ms IgG2a Hu nonconjugated Dako Millard  
et al., 1998 
caspases pAb - Rab IgG Hu, Rat, Ms PE-conjugated BD Biosciences Belloc  
et al., 2000 
perforin mAb dG9 Ms IgG2b Hu PE-conjugated BD Biosciences Gerner  
et al., 2008 
Ki67 mAb B56 Ms IgG1,κ Ms FITC-
conjugated 
BD Biosciences Gerner  
et al., 2008 
Bax, Bcl-xL, Mcl-1 pAb - Rab IgG Ms/ Rab/ Hu unconjugated Santa Cruz 
Biotechnology 
van Stijn  
et al., 2003 
Viral particles        
HIV mAb unknown MsIgG1b12 Hu unknown Denis Burton Mascola  
et al., 2002 
Receptors or their 
proteins, enzymes 
       
Steroid hormone 
receptor proteins  
mAb 
pAb 
(various) (various) (various) (various) Afinity 
bioreagents 
Butts  
et al., 2007 
Cox1/2 mAb AS70, 
AS67 
Ms IgG1,κ Hu FITC, PE BD Biosciences Ruitenberg  
et al., 2003 
Estrogen 
Receptor α 
mAb 1D5 Ms IgG1 Hu unconjugated Dako Cao  
et al., 2000 
Phospho-proteins        
Akt mAb 
pAb 
5G3 
- 
Ms IgG1 
Rab IgG 
Hu, Ms, Rat, Hm 
Hu, Ms, Rat, Hm, 
Mk, Chick, Dm, 
Bov, Pig, Dog 
unconjugated Cell Signaling 
Technology 
Tazzari et 
al., 2002 
MEK1/2 pAb - Rab IgG Hu, Ms, Rat, Mk, 
Sc 
unconjugated Cell Signaling 
Technology 
Chow  
et al., 2001 
ERK1/2 mAb 20A Ms IgG1 Hu, Ms, Rat AF-conjugated BD Biosciences Krutzik  
et al., 2003 
JNK mAb 41 Ms IgG1 Hu unconjugated BD Biosciences Krutzik  
et al., 2003 
p38 MAPK mAb 30 Ms IgG1 Hu, Rat, Ms unconjugated BD Biosciences Krutzik  
et al., 2003 
Stat1 mAb 14 Ms IgG1,κ Hu, Ms unconjugated BD Biosciences Krutzik  
et al., 2003 
Stat3 mAb D3A7 Rab IgG Hu, Ms, Rat, Mk AF-conjugated Cell Signaling 
Technology 
Kalaitzidis  
et al., 2008 
Stat4 pAb - Rab IgG Hu, Ms unconjugated Invitrogen Uzel  
et al., 2001 
Table 1. continues on next page 
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Intracellular 
marker 
Type Clone 
name 
Isotype Reactivity Labelling Source Ref. 
Stat5 mAb 47 Ms IgG1 Hu AF-conjugated BD Biosciences Krutzik  
et al., 2003 
Stat6 mAb 18 Ms IgG2a Hu PE-conjugated BD Biosciences Krutzik  
et al., 2003 
CD79a mAb HM57 Ms IgG1 Hu PE-conugated Dako Gerner  
et al., 2008 
mTOR mAb D9C2 Rab IgG Hu, Ms, Mk, (Rat) unconjugated Cell Signaling 
Technology 
Kalaitzidis  
et al., 2008 
Hu – human; Ms – mouse; Mk – monkey; Hm – hamster; Dm – drosophila melanogaster; Bov – bovine; 
Sc – saccharomyces cerevisiae; Mk – mink; Qua - quail 
Table 1. Intracellular antigens for flow cytometry 
A method for the direct labeling of antibodies that share the same subclass was tested. 
Because it was necessary to label relatively small amounts of antibodies, the Zenon-labeling 
technology was chosen.  
The Zenon reagents are provided by Invitrogen. This labeling involves the binding of Fab 
fragments of the fluorochrome-labeled, subclass-specific secondary antibody to the primary 
antibody, prior to the labeling of the cells. The excess of the fluorochrome-labeled secondary 
antibody is neutralized by addition of irrelevant mouse antibody in excess, which is 
supplied within the Zenon kit. The disadvantage of these reagents is the relatively high 
price. The price is the same for all fluorochromes; however, the number of reactions that can 
be performed by the kit differ among fluorochromes. Packages with Alexa Fluor, FITC, 
Texas Red and Pacific dyes contain reagents for 50 rounds of labeling, packages with 
phycobiliprotein dyes such as R-PE or APC contain reagents for 25 rounds of labeling, and 
packages with tandem dyes contain reagents for only 10 rounds of labeling. Therefore, it is 
advantageous to choose Zenon reagents containing Alexa Fluor dyes.  
The other disadvantage of the Zenon labeling is that the fluorescence yield of Zenon-labeled 
antibodies is slightly lower compared to classical indirect labeling. Therefore, antibodies 
against strongly expressed markers should be preferably stained with the Zenon reagents. 
(Ondrackova et al., 2010, 2011) 
General protocol for cell surface staining followed by intracellular labeling 
1. Place the samples of cell suspensions into a U-bottom 96-well plate, spin the plate, 
remove as much supernatant as possible, and vortex the plate. 
If viability staining with permanent dye combined with intracellular staining is 
performed, then: 
2. Add the viability staining dye, incubate according the manufacturer’s instructions, 
vortex the plate, and wash once. 
The cell surface staining is performed as follows: 
3. Add the cocktail of primary antibodies against cell surface molecules in a total volume 
of 10 μl (dilute antibodies in CWS) + 10 μl of heat-inactivated, filtered goat serum, 
vortex the plate, incubate for 15 min at 4°C, and wash twice. 
4. Add a secondary antibody cocktail in total volume of 25 μl (dilute antibodies in CWS), 
vortex the plate, and incubate for 20 min at 4°C. 
If the cell surface molecules are to be labeled with Zenon reagents or if intracellular 
staining follows, then: 
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5. Wash once and vortex the plate thoroughly because the plate in the next step cannot be 
vortexed due to the risk of the samples overflowing into the neighboring wells. 
6. Add 100 μl of heat-inactivated, filtered mouse serum diluted 1:10 in CWS, incubate for 
20 min at 4°C, and wash once. 
Labeling cell surface molecules with Zenon-labeled antibodies now follows, but this 
step can be omitted if it is not required: 
7. Add the cocktail of Zenon-labeled antibodies against cell surface molecules in a total 
volume of 10 μl, incubate for 15 min at 4°C, vortex the plate, and wash –twice. 
Staining of intracellular molecules with directly-labeled, Zenon-labeled, or unlabeled 
antibodies follows, but these steps can be omitted if they not required: 
8. Add 30 μl of Solution A from the IntraStain kit, vortex thoroughly to allow complete 
hemolysis of contaminating red blood cells, incubate for 15 min at room temperature, 
and wash –twice. 
9. Add primary antibodies against intracellular molecules (directly-labeled, Zenon-
labeled, or unlabeled) diluted in Solution B from the IntraStain kit in a total volume of 
20 μl, vortex the plate, incubate for 20 min at room temperature, and wash twice. 
10. Add secondary antibodies diluted in Solution B from the InraStain kit and CWS (ratio 
of Solution B and CWS 1:1) in total volume of 25 μl, incubate for 20 min at room 
temperature, wash twice. 
11. Resuspend samples in CWS in the volume that is required for the subsequent 
measurement and measure by the appropriate method. 
CWS solution: PBS containing 1.84 g/l EDTA, 1 g/l NaN3, 4 ml/l gelatin from cold water 
fish skin 
Wash definition: Add as much CWS into each well as possible, spin 3 min at 500 g, remove 
much supernatant as possible, and vortex. 
 
(a) 
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(b) 
Fig. 3. Seven color flow cytometry for identification of porcine monocyte subpopulations 
using two Zenon-labeled antibodies 
The red blood cells from the whole peripheral blood or from the bone marrow sample were 
lysed with ammonium chloride solution. The following fluorescent staining was performed: 
Primary antibody Secondary antibody / Zenon reagent / viability stain 
 E
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tio
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 w
av
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en
gt
h 
Target 
molecule 
Clone Manufacturer Amount 
per well
Stained 
at point
Class/
subclass
Fluorochrome Manufacturer Dilution Stained 
at point 
488 CD163 2A10/
11 
VMRD, USA 0.1 μl 3) IgG1 AlexaFluor488 Invitrogen, 
USA 
1:750 4) 
488 CD14 MIL-2 Serotec, UK 1 μl 3) IgG2b AlexaFluor647 Invitrogen, 
USA 
1:750 4) 
488   Propidium iodide 11) 
488 SLA-DR MSA3 VMRD, USA 0.05 μl 3) IgG2a PE-Cy5.5 Invitrogen, 
USA 
1:100 4) 
488 SWC8 MIL-3 Dr. J.K. 
Lunney * 
1 μl 3) IgM DyLight405 GeneTex, 
USA 
1:500 4) 
640 CD172α DH59
B 
VMRD, USA 0.1 μl 7) Zenon 
IgG1 ** 
AlexaFluor647 Invitrogen, 
USA 
  
640 CD203α PM 
18-7 
Serotec, UK 0.1 μl 7) Zenon 
IgG1 ***
APC-
AlexaFluor750
Invitrogen, 
USA 
  
* a generous gift from Dr. J.K. Lunney, Animal Parasitology Institute, Beltsville, MO, USA 
** labeling with the Zenon® AlexaFluor647 Mouse IgG1 Labeling Kit perform as follows: 0.1 μl of anti-
CD172α and 0.5 μl of Solution A of the Zenon Kit, mix well, incubate 10 min at 4°C, then add 0.5 μl of 
Solution B of the Zenon kit, mix well, incubate 10 min at 4°C 
*** labeling with the Zenon® APC-AlexaFluor750 Mouse IgG1 Labeling Kit perform as follows: 0.1 μl of 
anti- CD203α and 0.5 μl of Solution A of the Zenon kit, mix well, incubate 10 min at 4°C, then add 0.5 μl 
of Solution B of the Zenon kit, mix well, incubate 10 min at 4°C 
The measurement was performed by using BD FACSAria I flow cytometer (Becton Dickinson, USA). 
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The gating strategy for identification of monocytes in the bone marrow is depicted (A). 
Briefly, the leukocytes were gated according their light scatter properties (upper left dot-
plot). The dublets of cells were excluded from the further analysis (upper middle dot-plot). 
The viable (propidium iodide-negative) cell were gated (upper right dot-plot). The CD203α-
positive macrophages were excluded (lower left dot-plot). The monocytes were identified as 
SWC8-negative (lower middle dot-plot) CD172α-positive cells (lower right dot-plot).  
Then monocyte subpopulations from the bone marrow and peripheral blood were identified 
based on expression of SLA-DR, CD14 and CD163 (B). The SLA-DR-positive and negative 
monocytes were gated (left dot-plots). Then SLA-DR-negative (middle dot-plots) and SLA-
DR-positive (right dot-plots) monocyte subpopulations were depicted in CD163 vs. CD14 
dot-plots. 
 
Fig. 4. Six color flow cytometry for measurement of IL-8 production by monocyte 
subpopulations using the Zenon-labeled anti-IL-8 antibody 
The gating order for evaluation of IL-8 production by monocyte subpopulations is depicted 
(A). Briefly, the leukocytes were gated according their light scatter properties (B). The 
dublets of cells were excluded excluded from the further analysis (C). The viable 
(LIVE⁄DEAD® Fixable Aqua Dead Cell Stain-negative) cell were gated (D). The monocytes 
were identified as SWC8-negative CD14-positive cells (E). The IL-8 production by CD163-
positive and negative monocytes (F) and by SLA-DR-positive and negative monocytes (G) 
was then evaluated. 
The whole peripheral blood diluted 1:1 with RPMI 1640 was stimulated for 2 hours with 
LPS (1 μg/ml) in the presence of brefeldin A (10 μg/ml). The red blood cells were lysed 
with ammonium chloride solution. The following fluorescent staining was performed: 
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Primary antibody Secondary antibody / Zenon reagent / viability stain 
E
xc
it
at
io
n 
w
av
el
en
gt
h 
Target 
molecule 
Clone Manufacturer Amount 
per well
Stained at 
point 
Class/subclass Fluorochrome Manufacturer Dilution Stained 
at point 
405 SWC8 MIL-3 Dr. J.K. Lunney * 1 μl 3) IgM DyLight405 GeneTex, USA 1:500 4) 
405   LIVE⁄DEAD® Fixable Aqua Dead Cell Stain Kit ** 2) 
488 CD163 2A10/11 VMRD, USA 0.1 μl 3) IgG1 AlexaFluor488 Invitrogen, USA 1:750 4) 
561 IL-8 8M6 Serotec, UK 0.2 μl 9) Zenon IgG1 *** R-PE Invitrogen, USA   
561 SLA-DR MSA3 VMRD, USA 0.05 μl 3) IgG2a PE-Cy5.5 Invitrogen, USA 1:100 4) 
640 CD14 MIL-2 Serotec, UK 1 μl 3) IgG2b AlexaFluor647 Invitrogen, USA 1:750 4) 
* a generous gift from Dr. J.K. Lunney, Animal Parasitology Institute, Beltsville, MO, USA 
** diluted 1:1000 in PBS, 10 μl / well, incubation15 min at 4°C 
*** labeling with the Zenon® R-Phycoerythrin Mouse IgG1 Labeling Kit perform as follows: 0.2 μl of 
anti-IL-8 and 4 μl of Solution A of the Zenon kit, mix well, incubate 10 min at 4°C, then add 4 μl of 
solution B of the Zenon kit, mix well, incubate 10 min at 4°C, then add 11.8 μl of Solution B of IntraStain 
kit 
The measurement was performed by using BD LSRFortessa flow cytometer (Becton Dickinson, USA) 
5. Intracellular measurement of the p-CrkL and CrkL levels using flow 
cytometry 
5.1 Theoretical background 
Chronic myeloid leukemia (CML) is a myeloproliferative disorder of hematopoietic stem 
cells that is characterized by the presence of the BCR-ABL fusion gene, which encodes the 
constitutively active BCR-ABL tyrosine kinase (Daley et al., 1990). Currently, the tyrosine 
kinase inhibitor imatinib (IM) (a potent inhibitor of BCR-ABL) is used as a first line therapy 
for CML patients (Baccarani et al., 2009). 
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Fig. 5. The equivalence between flow cytometry and Western blot methods, in p-CrkL 
reduction in a BCR-ABL positive K562 cell line after 48 h treatment with imatinib (Hamilton 
et al., 2006) 
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The CrkL protein is a downstream signaling substrate of BCR-ABL, and its tyrosine 
phosphorylation (p-CrkL) serves as a specific indicator of BCR-ABL kinase activity in CML 
cells (Nichols et al., 1994; Patel et al., 2006). Recent studies have revealed that p-CrkL can act 
as a prognostic marker for imatinib treatment response of CML patients using either 
western blotting (White et al., 2005) or flow cytometry (Lucas et al., 2010). However, certain 
discrepancies have been found in the literature concerning the predictive value of p-CrkL in 
different cell types (mononuclear cells or CD34+ cells) used for analysis (Khorashad et al., 
2009). 
The technique for measuring p-CrkL levels using flow cytometry was originally described 
by Hamilton et al., (Hamilton et al., 2006) and the equivalence between flow cytometry and 
western blot methods was demonstrated (Figure 5). 
5.2 The technique of intracellular p-CrkL and CrkL measurement by flow cytometry 
Mononuclear cells (MNCs) were isolated from PB of newly diagnosed CML patients using 
Histopaque-1077 density gradient centrifugation (Sigma–Aldrich, St. Louis, MO, USA) and 
subsequently enriched for CD34+ cells using magnetic-activated cell sorting (MACS) with a 
CD34 MicroBead Kit (Miltenyi Biotec, Bergisch Gladbach, Germany) according to the 
manufacturer’s instructions. CD34+ cells (5x104) were incubated for 16 h with 0, 0.5, 1.5, and 
5 μM imatinib in 1 ml of serum-free medium (SFEM), supplemented with StemSpan CC100 
cytokine mixture (StemCell Technologies, Köln, Germany) as previously described (Koutna 
et al., 2011). Then the cells were washed in phosphate buffered saline (PBS) and fixed with 
4% formaldehyde for 10 min at 37°C, then washed in PBS and permeabilized by 90% 
methanol at 4°C for 30 min. 
After permeabilization, the cells were washed in PBS and incubated with primary unlabeled 
antibody for 30 min at 4°C in 100 μl of FACS incubation buffer (0.5% bovine serum albumin 
in PBS). The concentration of primary antibodies was 12 µg/ml (p-CrkL, Cell Signaling 
Technology, Danvers, MA, USA; CrkL, Santa Cruz biotechnology, Santa Cruz, CA, USA; 
isotype control anti-normal-rabbit IgG G, R&D Systems, Minneapolis, MN, USA). The cells 
were washed in FACS incubation buffer and incubated with FITC-conjugated anti-rabbit 
IgG secondary antibody (Sigma-Aldrich) in a concentration of 10 µl/ml. 
All samples were measured on a FACSCanto II Flow Cytometer (Becton Dickinson). For 
data analysis, BD FACSDiva (Becton-Dickinson) and FlowJo (Tree Star, Ashland, USA) 
software were used. The viable cell population was gated according to forward scatter and 
side scatter parameters. The level of p-CrkL and CrkL in the viable cells was determined as 
the geometric mean fluorescence intensity (MFI) of the p-CrkL- or CrkL-labeled sample 
minus the MFI of the isotype control (Figure 6).  
The IC50imatinib was defined as the concentration of imatinib that caused a 50% decrease in 
the amount of p-CrkL compared to the untreated control (Figure 7) (White et al., 2005). The 
p-CrkL/CrkL ratio was calculated by dividing the concentrations of p-CrkL by those of 
CrkL and multiplying by 100 in untreated cells (Lucas et al., 2010). The p-CrkL ratio was 
assessed as a percentage of p-CrkL in the samples treated with a maximal imatinib 
concentration (5 µM) relative to the untreated control (Figure 7) (Khorashad et al., 2009). 
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Fig. 6. Representative FACS plot showing isotype, p-CrkL and CrkL MFI peaks in CD34+ 
cells isolated from peripheral blood of a newly diagnosed CML patient. Changes in p-CrkL 
MFI peaks following in vitro imatinib (IM) treatment are detectable and were visualized 
using FlowJo software 
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Fig. 7. The graph of p-CrkL decrease upon in vitro imatinib treatment. MFI peaks 
quantification was calculated in FlowJo software 
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